National Alliance on Mental Illness
page printed from http://www.nami.org/
(800) 950-NAMI; info@nami.org
©2013
Schizophrenia and Schizoaffective Disorder Research Studies
Living with schizophrenia (or schizoaffective disorder) and experiencing involuntary movements?
Date: April 18, 2013
If so, you’re invited to see if you may qualify for a medical research study to determine if an investigational drug may help you manage your involuntary movements.
To learn more, visit www.KinectStudy.com.Participate in Research: Schizophrenia and the Family
Date: April 18, 2013
My name is Rachel Morton from the School of Psychology and Counselling at the Queensland University of Technology. I’m researching the experience of family members who have lived with or are living with a close family member who has been diagnosed with schizophrenia. I would like to know what you do to cope with stress, your own personal characteristics, including some questions about your medical history, your levels of stress and any potential benefits.
We are looking for:
- First degree family members (eg. parents, siblings or children) of those diagnosed with schizophrenia (aged 16 and over)
- Who have lived with your relative at some point since their diagnosis
Participation involves:
- Completing an online questionnaire package about your experiences of living with someone who has schizophrenia. Your participation is expected to take 20-25 minutes.
Participants will have the opportunity to enter into a draw upon completion receive one of two $50 shopping vouchers.
If you are ready to participate now please go to this link for more information and to complete the survey, http://survey.qut.edu.au/f/175766/c9eb/
Many thanks for your consideration of this request.If you or a loved one suffer from schizophrenia, schizoaffective disorder, bipolar disorder, or a gastrointestinal disorder and are experiencing involuntarymovements in your face or other parts of your body, you may qualify for a medical research study.
Date: April 18, 2013
If you have schizophrenia, schizoaffective disorder, bipolar disorder, or a gastrointestinal disorder (including trouble with reflux and/or gastric emptying) and experience symptoms of tardive dyskinesia, you’re invited to see if you may qualify for a clinical research study to determine if an investigational drug may help you manage your involuntarymovements.
Each individual must be 18 to 85 years of age, and will be evaluated to determine eligibility. All participants will receive study-related medical exams and lab tests at no charge. Compensation for time and travel may be available.
Have You Been Diagnosed With Schizophrenia?
Date: March 5, 2013
If you have been diagnosed with schizophrenia, you may qualify to participate in a clinical research study with an investigational medication for schizophrenia being conducted by Comprehensive Clinical Development.
Qualified participants between ages 18 to 65 will receive, at no cost, all study related care including:
- Psychiatric evaluations
- Study related medical care and
- Study medication
You may be compensated for time and travel during participation and insurance is not needed.
Call Comprehensive Clinical Development at 727-576-8474 to see if you may qualify or for more information or visit website at www.comprehensivecd.com.
“Gating and Inhibition in Schizophrenia,” Principal Investigator: Dr. David L. Braff
Location: San Diego, California
Age: 18-65
Date: February 28, 2013
Researchers from the University of California, San Diego, in the Department of Psychiatry need men and women ages 18 – 65 with a diagnosis of schizophrenia for a research study investigating how the brain processes information.
Participation will include:
- A brief interview about your medical & psychiatric history
- Completion of a series of problem-solving tests
- Measurements of your eye blinks and brainwaves
- Recordings of your eye movements
- You will be compensated $10 per hour for your time
- Testing may last 1 to 7 hours
Persons Eligible:
- Males or Females between ages 18-65
- Have a diagnosis of schizophrenia
Persons NOT Eligible:
- Current substance abuse
- Significant, unstable medical illness
If you are interested in participating please call Natalie or Lauren at (619) 543-7201 or email nmccarthy@ucsd.edu
Emotion in Schizophrenia and Bipolar Disorder
A VA Greater LA Healthcare System & UCLA study - Principal Investigator, William P. Horan, Ph.D
Date: February 28, 2013
What is this study about?
- The purpose of this research study is to understand how the brain functions when processing emotional information in people with schizophrenia or bipolar disorder. The study will involve electroencephalography (EEG) and psychophysiological techniques to obtain images of brain activity involved in processing emotional information.
Who is eligible?
- We are looking for people who have a diagnosis of schizophrenia or bipolar disorder. In addition, you must be 18-60 years of age, not have a significant neurological condition (i.e. epilepsy, multiple sclerosis, etc.), have no history of serious head injury, and no evidence of drug or alcohol abuse in the past 6 months, and no metal or medical implants in the body.
What do you have to do?
- You may be asked questions about your personal history
- You may be asked to perform emotional processing and decision making tasks while EEG equipment records electrical activity in your brain
- You will be asked to perform a picture viewing task that will include images that might be experienced as scary, disturbing, or uncomfortable
- There is no medical benefit to you for participation. You will receive compensation for participation, parking, and travel.
How long does it take?
- The interview will last approximately 1 hour and 45 minutes
- The EEG procedures will be from 2 to 3 hours
What are the risks?
- The EEG recording involves remaining still in a seated position, so you may feel uncomfortable
- You may experience some slight discomfort on your scalp from the EEG recording equipment
- Some picture may make you feel uncomfortable
What do you receive?
- There is no medical benefit to you for participation. You will receive compensation for participation, parking, and travel.
Please contact Amanda Bender, MS 310-478-3711 ext. 49234 for more information
Medication Study for Weight Loss and Cognitive Improvement in Schizophrenia
Date: Oct. 6, 2011
Location: Boston, Massachusetts
Age: 18-65
Have you been diagnosed with schizophrenia or schizoaffective disorder?
Are you currently taking clozapine or olanzapine (Zyprexa)?
“Telmisartan as an Adjunctive Treatment for Metabolic Problems in Patients with Schizophrenia,” Principal Investigator: Dr. Xiaoduo Fan.
Researchers from the Massachusetts General Hospital, Psychiatry Department seek men and women ages 18-65 that have a diagnosis of schizophrenia or schizoaffective disorder and are treated with clozapine or olanzapine antipsychotic medications. This twelve-week research study examines the effects of telmisartan, a hypertension medication, on insulin resistance, body composition and symptoms of schizophrenia when added to a treatment of clozapine or olanzapine. We are interested in learning whether telmisartan improves how the body manages insulin levels, decreases waist circumference and stomach fat, and thereby decreases the risk of diabetes and cardiovascular disease. Participants are compensated up to $205.
Persons Eligible:
- Males or Females between ages 18-65
- Have a diagnosis of schizophrenia or schizoaffective disorder
- Currently taking clozaril (Clozapine) or olanzapine (Zyprexa)
Persons NOT Eligible:
- Current substance abuse
- Treatment with insulin, spironolactone, diboxin, warfarin or diuretics
- Significant, unstable medical illness
Enrollment Information:
If you are interested in participating or would like to make a referral, please call
Claire Oppenheim at (617) 912-7837 or email coppenheim@partners.org.
Do you have a parent, child or sibling living with schizophrenia, schizoaffective disorder, or bipolar disorder?
Age: 18+
Location: By telephone, web or email.
If you answered "yes", we would love to hear from you! We are UBC researchers who have developed a questionnaire to help measure internalized stigma in first-degree relatives of people living with a severe mental illness.
What is the purpose of the research?
Stigma affects individuals living with a mental illness and their family members. The purpose of this study is to validate a questionnaire that we have recently developed to measure internalized stigma in first-degree family members (parents, brothers, sisters, and children) of people with schizophrenia, bipolar disorder, or schizoaffective disorder. The questionnaire will be used to gather information about how family members of people living with mental illness experience stigma, which can also be helpful in evaluating the well being of family members. Later on, the questionnaire will also be used in the development and evaluation of strategies to reduce individuals’ internalized stigma.
Who can participate?
Parents, siblings, and children of people living with schizophrenia, schizoaffective disorder, or bipolar disorder. We are looking for both men and women to participate in this study.
What is involved in participating?
If you participate in this study you will be asked to complete questionnaires at two time points that are one month apart. The questionnaires include the new stigma questionnaire as well as seven other questionnaires (that ask about things like self-esteem and mood).
You do not have to travel to participate in this study; you can participate entirely from home by telephone and mail or email.
Each time point should take approximately 30 to 45 minutes of your time to complete.
How do I participate?
If you are interested in participating, please contact the Research Coordinator (Emily) at: (604) 875-2000 x4732 or by email at mental.illness@ubc.ca
Posted: August 10, 2010
Schizophrenia and Bipolar Disorder Family Genetic Research Study
Age: 15-65
Location:
The University of Chicago along with the University of Illinois at Chicago are seeking individuals in the Chicago area who live with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder with psychotic features with available immediate family members to participate in our genetic study. Family members do not have to have mental health symptoms to participate. The overall goal of this research is to improve our understanding about the biological causes of these illnesses so that we can develop better treatments to improve and eventually restore the lives of patients who live with them. This study is overseen at the
Participants will undergo a 2-4 hour diagnostic interview at the
Contact the study line at 866-51-GENES or 773-834-3560 for more information. More information is provided on our website: http://www.ucfamily.org/familystudies/main.html.
Posted: 1 September 2009
NIMH Genetic Study of Schizophrenia Protocol # 95-M-0150
The Schizophrenia Research Program at the National Institute of Mental Health located at on the campus of the National Institutes of Health in Bethesda, Maryland, is seeking healthy adults diagnosed with schizophrenia or schizoaffective disorder (depressed type) to participate in a two-day outpatient study. Travel and lodging assistance is provided and a stipend is also given to participants. This study seeks to identify the genetic and environmental factors that increase the risk of developing schizophrenia. The procedures include confidential interviews and a blood draw, a neurological exam and neuropsychological testing, neuroimaging, and recordings of brain waves. Siblings are also invited to participate in these procedures and parents are invited to give a sample of blood if possible. For more details, call the toll-free schizophrenia studies referral line at 1-888-674-6464 (TTY: 866-411-1010) at NIH, Department of Health & Human Services.
NIMH Seeks Volunteers for Six-Month Schizophrenia Study
The Schizophrenia Research Program at the National Institute of Mental Health specializes in the field of schizophrenia and is conducting a six-month inpatient research study of the neurobiological causes of schizophrenia at the National Institutes of Health in Bethesda, Maryland. The program involves extensive psychological, psychiatric, neurological, and medical evaluations, and neuroimaging. Study participation involves a period of time without medications. Throughout their stay in the research program, participants receive expert, personalized care, and are encouraged to participate in the clinical milieu that provides educational programs, recreational and occupational therapy, and art and music therapies. Participants must be between the ages of 18 and 50, be diagnosed with schizophrenia or schizoaffective disorder, and be free of significant medical/neurological illnesses and active substance abuse. There is no charge to participate. For more details, call the schizophrenia research referral line at 1-888-674-6464, (TTY: 866-411-1010) at NIH, Department of Health & Human Services.
Schizophrenia and Bipolar Disorder Family Genetic Research Study
Location:
Age: 15-65
The
You may be eligible to participate in the study if you meet these conditions:
- Age between 15-65 years
- Diagnosis of schizophrenia, schizoaffective disorder or bipolar disorder (with psychosis)
- Have at least one biological first-degree relative, i.e., a sister, brother, mother or father willing to participate. The relative does not need to be diagnosed with a psychiatric disorder but it is ok if they are
- No serious medical, neuro-opthalmological or neurological illness (e.g., cancer, seizure disorders, encephalopathy)
- No current substance abuse (within past 3 months) or past history of substance dependence (within 6 months or extensive history)
- No ferromagnetic objects lodged in the body
Participation involves:
- Clinical interviews to evaluate diagnosis and gather other personal information
- Neuropsychological Tests to examine thinking abilities such as attention and memory
- Electroencephalography (EEG)/Sensory Gating tests to measure brain activity in response to sounds
- Eyetracking tests to measure eye movements and visual attention
- MRI to measure brain structures and function
- Blood sample for DNA (genetic) studies
- Urine sample to screen for drugs and pregnancy
The total amount of time it takes to complete the study is approximately 14-16 hours. Transportation can be provided if needed. All participants will be compensated for their time.
For more details, call our research coordinator, Jennifer Jones, at 410-402-6823
Posted: April 15, 2009
Cognitive-Behavior Therapy (CBT) for Psychosis Study
Age: 18-45
Location: Columbia University and The New York State Psychiatric Institute,
Study End Date: 2012
This study examines the impact of Cognitive-Behavior Therapy (CBT) on symptoms, physiological arousal, stressors, and the ways to deal with them in individuals with schizophrenia. The primary aim of this study is to investigate the role cognitive coping strategies play in mediating the link between stress, physiological arousal and psychotic symptoms in individuals with schizophrenia during recovery from psychosis.
Study Design: Participants will be randomized to receive either standard psychiatric treatment or up to 26 weekly sessions of individual CBT to target hallucinations and/or delusions in addition to standard psychiatric treatment. All participants may continue to receive treatment from their current psychiatrist during the study. Participants will complete research assessments at the beginning of the study and after 10, 20, and 30 weeks. These will include interviews, questionnaires, and neuropsychological tests, as well as monitoring sessions of heart rate and experiences. For more information, please see http://clinicaltrials.gov/show/NCT00791440.
Persons eligible:
- Males or females between ages 18-45.
- English speaking.
- Have a diagnosis of schizophrenia, or schizoaffective disorder, or schizophreniform disorder.
- Experience frequent hallucinations or delusions (for example: suspicious thoughts, and/or hear voices that other people can’t hear, and/or see things that other people can’t see).
Persons Not Eligible:
- Have a history of heart problems or hypertension.
- Is using regularly any medications for heart problems or hypertension.
- Have used street drugs within the past 4 weeks.
- Have history of having active suicidal plans or serious self-destructive, violent or aggressive behavior during the past 5 years.
- Have history of neurological disorders or medical conditions known to seriously affect the brain.
Payment:The CBT treatment is provided free of charge. Participants may receive up to $350 (over ~7 months) for completing the four research assessments including the interviews, questionnaires, neuropsychological tests, monitoring sessions of heart rate and experiences, and providing two urine samples.
Contact: David Kimhy, Ph.D.
Contact Information: (212) 543-6817 or kimhyda@pi.cpmc.columbia.edu
Posted: March 27, 2009
Have You Ever Been Diagnosed with Schizophrenia?
Age: 18-90
Location:
You may be able to participate in a research study to better understand schizophrenia.
- You must be between the ages of 18 and 90,
- You will be asked to complete a brief questionnaire, a discussion of your health history, and provide a small blood sample, and
- You will receive compensation for your time and travel if you complete the study.
For more information, or to make an appointment, please call Brandi Palmer, MS, PC or Douglas Lehrer, MD at 937-395-8227.
The
Posted: March 4, 2009
Are You Currently Employed in Volunteer or Paid Employment and Have a Diagnosis of Schizophrenia or Psychotic Disorder?
Age: 18+
Location: Web survey
My name is Jenessa Fisk. I am a graduate student in Occupational Therapy at
The results will be used to guide how occupational therapists and other rehabilitation specialists can work with individuals with schizophrenia and other psychotic disorders to find and keep a job (paid or volunteer). To view and participate in the online survey, please click the link below. If the link does not directly connect you to the survey, please copy and paste it into your web browser.
https://www.surveymonkey.com/s.aspx?sm=7Fuq4_2b1mKsFKRy73dfNU7A_3d_3d
If you have any questions about the survey or being a participant, please contact me at jfisk1@ithaca.edu or contact Dr. Judy Gonyea, my thesis advisor, at (607) 274-1737 or jgonyea@ithaca.edu.
All information will remain confidential.
Thank you.
Posted: February 17, 2009
Seeking persons with persistent auditory hallucinations or voices for TMS clinical trial in New Haven CT
Age: 18-55
Location: New Haven, CT
Investigational treatment for persons with auditory hallucinations ("voices") using Transcranial Magnetic Stimulation is being studied at Yale School of Medicine. We are seeking participants who:
- hear "voices" at least 3-4 times per day;
- are between ages 18-55;
- do not have a significant neurological condition such as epilepsy.
Study duration is 4-8 weeks. Reasonable transportation costs to and from
Posted: February 17, 2009
Schizophrenia… It Can Decrease Your memory and Thinking Ability
Age: 18-55
Location:
Have you been diagnosed with schizophrenia? Are you currently being treated with a stable dose of Seroquel ®, Zyprexa ®, Risperdal ®, or Abilify ®?
If so, and you are 18-55, you may qualify to participate in a research study to learn about the effects of an investigational drug on cognitive function in individuals with stable schizophrenia. Qualified participants may receive at no cost study-related:
-
Psychiatric evaluations
-
Study drug
-
Follow-up visits
-
Compensation for time and travel
Contact: Center for Emotional Fitness,
Posted: February 17, 2009
Are you or is someone you know being treated for Schizophrenia?
Location:
The MGH Schizophrenia Program has several research opportunities in the areas of genetics, health and weight management, brain imaging and new treatments: both psychological and medical.
Compensation for time & transportation provided.
Please call us at: 617-912-7828.
Principal Investigator - Donald Goff, MD
Posted: 14 October, 2008
Genetic Study of Schizophrenia
Age: 18-70
Location:
The Massachusetts General Hospital Schizophrenia Program is conducting a research study to better understand the genes involved in the symptoms of schizophrenia. We are seeking volunteers diagnosed with schizophrenia ages 18 to 70. The study involves one three-hour visit which includes a blood draw for four tubes of blood and a series of interviews and cognitive (thinking processes) testing. If you wish, your psychiatrist may receive a report of the cognitive test results. Payment of $30 is provided for participation. Transportation reimbursement is available. Please contact Kelsey at 617-912-7868 or via e-mail at kshannahan@partners.org if you are interested in learning more about this study.
Posted: 14 October, 2008
Are you being treated for schizophrenia or schizoaffective disorder?
Age: 18-65
Location:
The Schizophrenia Program at the
Antipsychotic medication (Consta or oral second generation) is provided free of charge during participation. Remuneration will be up to $800 with an average remuneration of $160 every 6 months. Transportation reimbursement is available.
Please contact Jared Walsh at (617) 912-7864 or via e-mail at jpwalsh@partners.org if you are interested in the study.
Posted: 14 October, 2008
Are you being treated for schizophrenia?
Age: 18-68
Location:
The Schizophrenia Program at the
Posted: 14 October, 2008
Medication Study of Learning and Memory in Schizophrenia
Age: 18-60
Location:
The Massachusetts General Hospital Schizophrenia Program is conducting a research study to compare the effects of an investigational medication (MK-0777) versus placebo (contains no active medication) on attention, learning and memory. We are seeking volunteers diagnosed with schizophrenia ages 18 to 60 who are currently taking one of the following medications: risperidone, risperidone microspheres, aripiprazole, olanzapine, ziprasidone or quetiapine. The study involves taking either the study medication or the placebo for a total of 6 weeks. Neither you nor your clinician will know if you are taking the active drug or the placebo during the study. There will be 10 visits over a period of 8 weeks, with additional follow up at 6 and 12 months. Remuneration of up to $180 will be provided. Transportation reimbursement is available. Please contact Jared at 617-912-7864 or via e-mail at jpwalsh@partners.org if you are interested in learning more about this study.
Posted: 14 October, 2008
Are you currently taking or considering taking Geodon for the treatment of schizophrenia or schizoaffective disorder?
Age: 18-65
Location:
The Schizophrenia Program at the
Geodon is an FDA-approved medication for the treatment of schizophrenia and schizoaffective disorder. Patients who are not currently taking 160mg/day can participate in an open-label phase (meaning that the subject will be taking active medication and will be aware of that) to reach the appropriate dose required for screening. Study medication is provided free of charge during the study and subjects will receive remuneration up to $175. Reimbursement for transportation expenses is available. Please contact Jared Walsh at (617) 912-7864 or via e-mail at jpwalsh@partners.org if you are interested in the study.
Posted: 14 October, 2008
ARE YOU TAKING ONLY ONE OF THE FOLLOWING: RISPERDAL, OLANZAPINE, SEROQUEL, ABILIFY AND EXPERIENCING ANY COGNITIVE IMPAIRMENT?
Age: 18-65
Study Location:
COGNITIVE IMPAIRMENTS INCLUDE:
- deficits in areas such as memory, attention, planning, and problem solving
- problems with verbal and visual learning
- having a hard time managing emotions
Medical researchers at UCSD are currently conducting a clinical research study to evaluate an investigational drug for the cognitive impairment in schizophrenia.
Participants must be between 18 and 65 years of age to be eligible.
Medical and psychological evaluations and study drug will be provided at no cost. Eligible participants will also receive reimbursement for time and travel.
For more information please call:
(866)550-UCSD
UCSD Department of Psychiatry
VOLUNTEERS NEEDED FOR RESEARCH
Study Location: San Francisco
Age: 18+
-
Have you been given the diagnosis of schizophrenia by a mental health professional?
- Are you at least 18 years old?
- Have you not experienced severe symptoms for at least 6 months?
Hello, my name is Nisha Fernandes, I’m an advanced graduate student at the California School of Professional Psychology,
I want to have a deep understanding of schizophrenia and its’ process so that I, and other clinicians may eventually learn how to effectively treat this phenomenon. In order for me to truly understand the experience of self in schizophrenia, I wish to talk with individuals who have gone through this process.
Interested persons will be asked to participate in a brief phone interview to determine if my study is a good fit for you, and if you meet criteria for my study. If you are eligible for my study, you will be invited to 2 confidential, individual interviews of up to 1.5 to 2.0 hours each at a mutually agreed upon location (my school, a park, coffee shop, etc.)
Volunteers who share their experience with me, by participating in my study, may find that it helps develop their own understanding of what they went through. It can also feel good to know that you are doing something that may eventually help others who are going through and will go through similar experiences with schizophrenia. Also, as a thank you for participating in my study, I will give you $50 at the end of the second interview.
If you are interested in volunteering, or have any questions at all about my study, please call (415) 519-2593 or email me StudyOnSelf@yahoo.com.
Posted: 8 April, 2008